Clinical trial
Effectiveness of Atypical Versus Conventional Antipsychotics in Treating…
NCT00237861 · Yale University, Other · Completed
Key facts
| NCT number | NCT00237861 |
|---|---|
| Title | Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia |
| Official title | Effectiveness of Atypical Vs Conventional Antipsychotics |
| Lead sponsor | Yale University, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | risperidone, olanzapine, quetiapine |
| Primary completion | Dec 1, 2002 |
| First posted | Oct 12, 2005 |
| Last update posted | Jun 6, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: